Objective To correlate fetal brain magnetic resonance imaging (MRI) findings with epilepsy characteristics and neurodevelopment at 2 years of age in children with tuberous sclerosis complex (TSC) to improve prenatal counseling. Study design This retrospective cohort study was performed in a collaboration between centers of the EPISTOP consortium. We included children with definite TSC, fetal MRIs, and available follow-up data at 2 years of age. A pediatric neuroradiologist masked to the patient's clinical characteristics evaluated all fetal MRIs. MRIs were categorized for each of the 10 brain lobes as score 0: no (sub)cortical lesions or doubt; score 1: a single small lesion; score 2: more than one small lesion or at least one large lesion (>5 mm). Neurologic manifestations were correlated to lesion sum scores. Results Forty-one children were included. Median gestational age at MRI was 33.3 weeks; (sub)cortical lesions were detected in 97.6%. Mean lesion sum score was 4.5. At 2 years, 58.5% of patients had epilepsy and 22% had drug-resistant epilepsy. Cognitive, language, and motor development were delayed in 38%, 81%, and 50% of patients, respectively. Autism spectrum disorder (ASD) was diagnosed in 20.5%. Fetal MRI lesion sum scores were significantly associated with cognitive and motor development, and with ASD diagnosis, but not with epilepsy characteristics. Conclusions Fetal cerebral lesion scores correlate with neurodevelopment and ASD at 2 years in children with TSC.
31 January 2021 in Journal of Neuropathology & Experimental Neurology
Complex cortical malformations (CCMs), such as hemimegalencephaly and polymicrogyria, are associated with drug-resistant epilepsy and developmental impairment. They share certain neuropathological characteristics including mammalian target of rapamycin (mTOR) activation and an atypical number of white matter neurons. To get a better understanding of the pathobiology of the lesion architecture, we investigated the role of neurite outgrowth inhibitor A (NogoA), a known regulator of neuronal migration. Epilepsy surgery specimens from 16 CCM patients were analyzed and compared with sections of focal cortical dysplasia IIB (FCD IIB, n = 22), tuberous sclerosis complex (TSC, n = 8) as well as healthy controls (n = 15). Immunohistochemistry was used to characterize NogoA, myelination, and mTOR signaling. Digital slides were evaluated automatically with ImageJ. NogoA staining showed a significantly higher expression within the white matter of CCM and FCD IIB, whereas cortical tubers presented levels similar to controls. Further analysis of possible associations of NogoA with other factors revealed a positive correlation with mTOR and seizure frequency. To identify the main expressing NogoA cell type, double staining revealed dysmorphic neuronal white matter cells. Increased NogoA expression is associated with profound inhibition of neuritic sprouting and therefore contributes to a decrease in neuronal network complexity in CCM patients.
BACKGROUND AND OBJECTIVES: Stereoelectroencephalography (SEEG) is central to invasive presurgical evaluation in drug-resistant epilepsy (DRE). We evaluated the accuracy, safety, and workflow efficiency of frameless neuronavigation-guided SEEG in routine clinical practice. METHODS: This retrospective single-center cohort included consecutive adult and pediatric patients with DRE who underwent SEEG between July 2016 and August 2025. Entry-point and target-point deviations were measured on postoperative computed tomography fused to the preoperative planning data set. Safety end points were perioperative complications. Operative duration and time per electrode were recorded. Comparative analyses between AdTech and Dixi systems were restricted to the primary-surgery cohort to maintain independent samples. A subgroup analysis examined procedures performed by experienced surgeons, defined as more than 250 implanted electrodes. RESULTS: Seventy-seven patients underwent 82 SEEG procedures. Across all procedures, 984 electrodes were implanted. The median number of electrodes per surgery was 13. The median entry-point and target-point deviations were 2.1 and 1.8 mm, respectively. Entry-point deviation did not differ between AdTech and Dixi electrodes in the primary-surgery cohort (2.1 vs 2.1 mm; P = .579), whereas target-point deviation was slightly lower with Dixi (1.6 vs 1.9 mm; P = .030). The duration of Dixi procedures was shorter than AdTech procedures (102 vs 186 minutes P < .001) and had lower time per electrode (10 vs 14 minutes; P < .001). Four minor hemorrhagic complications occurred (4.9%/procedure; 0.4%/electrode); no permanent neurological deficits, reoperations, hardware-related complications, or procedure-related deaths occurred. A seizure-onset zone was localized in 48 patients (62%), enabling subsequent resective or disconnective surgery. CONCLUSION: Frameless neuronavigation-guided SEEG achieved reproducible millimetric accuracy, low morbidity, and efficient workflow in a consecutive real-world cohort. These findings support frameless neuronavigation as a safe and scalable option for invasive presurgical evaluation in DRE.